Overcoming Key Regulatory Issues in Cell and Gene Therapies with Reliable and Expansive Expertise
By Emma Cheesman-Ungstrup
For this short interview Emma describes a few of her key takeaways from...
Meeting on the Mesa 2021 | Impact of COVID-19 on the advanced therapies sector
By Christian Schneider, MD
Christian discusses the effects of the COVID-19 pandemic on the advanced therapies sector